Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers [5]

Journal of the American College of Cardiology

Volumn 47, Issue 4, 2006, Pages 889-890

  Boos, Christopher J ^a   Lip, Gregory Y H ^b  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; SELECTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

DRUG EFFECT; DRUG MECHANISM; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LETTER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; HUMANS; RECEPTORS, ANGIOTENSIN;

EID: 32644431899     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.11.033     Document Type: Letter

References (13)

1. J.S. Healey, A. Baranchuk, E. Crystal Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers a meta-analysis J Am Coll Cardiol 45 2005 1832 1839
2. M.J. Mihm, F. Yu, C.A. Carnes Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation Circulation 104 2001 174 180
3. A. Frustaci, C. Chimenti, F. Bellocci, E. Morgante, M.A. Russo, A. Maseri Histological substrate of atrial biopsies in patients with lone atrial fibrillation Circulation 96 1997 1180 1184
4. M.D. Engelmann, J.H. Svendsen Inflammation in the genesis and perpetuation of atrial fibrillation Eur Heart J 26 2005 2083 2092
5. Q. Zhao, M. Ishibashi, K. Hiasa Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling Hypertension 44 2004 264 270
6. R. Tamarat, J.S. Silvestre, M. Durie, B.I. Levy Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways Lab Invest 82 2002 747 756
7. M. Ishibashi, K. Hiasa, Q. Zhao Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling Circ Res 94 2004 1203 1210
8. S.N. Psychari, T.S. Apostolou, L. Sinos Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation Am J Cardiol 95 2005 764 767
9. A. Goette, T. Staack, C. Rocken Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation J Am Coll Cardiol 35 2000 1669 1677
10. S. Cardin, D. Li, N. Thorin-Trescases, T.K. Leung, E. Thorin, S. Nattel Evolution of the atrial fibrillation substrate in experimental congestive heart failure angiotensin-dependent and -independent pathways Cardiovasc Res 60 2003 315 325
11. G.Y.H. Lip Does atrial fibrillation confer a hypercoagulable state? Lancet 346 1995 1313 1314
12. D.S. Conway, P. Buggins, E. Hughes, G.Y. Lip Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation J Am Coll Cardiol 43 2004 2075 2082
13. K. Watchell, M. Lehto, E. Gerdts Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol the Losartan Intervention for End Point Reduction in Hypertension (LIFE) study J Am Coll Cardiol 45 2005 712 719